Fluphenazine decanoate

氟奋乃静葵酸酯

Report date: 2023/02/27 20:00:18
NME

Base Information

Drug NameFluphenazine decanoate
Drug Alias Name氟非那嗪癸酸酯癸氟奋乃静Prolixin decanoateModiten depotModecate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Harvest Pharmaceutical Co LtdMitsubishi Tanabe PharmaAventis-Sanofi Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN05AB02
Related LinksWikipediaDrugBankKEGG